Tocilizumab is effective and safe for rheumatoid arthritis, with long-term studies supporting its use and comparable cardiovascular risk to tumor necrosis factor inhibitors. Real-world data indicate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback